Melatonin, the pineal gland and their implications for headache disorders

Cephalalgia

Volumn 25, Issue 6, 2005, Pages 403-411

  Peres, Mario Fernando Prieto ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b NONE   (Brazil)

Author keywords

Cluster headaches; Melatonin; Migraine; Pathophysiology; Pineal gland; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; CYTOKINE; DOPAMINE; FREE RADICAL; GLUTAMIC ACID; INDOMETACIN; MELATONIN; NITRIC OXIDE SYNTHASE; OPIATE; SEROTONIN;

AGING; ANTIINFLAMMATORY ACTIVITY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CLUSTER HEADACHE; DOPAMINE RELEASE; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; HEADACHE; HORMONE ACTION; HUMAN; MEMBRANE STABILIZATION; MIGRAINE; MOOD; NEUROPROTECTION; NEUROTOXICITY; PATHOPHYSIOLOGY; PINEAL BODY; REVIEW; SIDE EFFECT; SLEEP; TREATMENT INDICATION; TREATMENT OUTCOME; UPREGULATION;

CIRCADIAN RHYTHM; HEADACHE DISORDERS; HUMANS; MELATONIN; PINEAL GLAND; RANDOMIZED CONTROLLED TRIALS;

EID: 20044377634     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2005.00889.x     Document Type: Review

References (77)

1. Arendt J. Importance and relevance of melatonin to human biological rhythms. J Neuroendocrinol 2003; 15:427-31.
2. Turek FW, Dugovic C, Zee PC. Current understanding of the circadian clock and the clinical implications for neurological disorders. Arch Neurol 2001; 58:1781-7.
3. Lerner AB, Case JD, Takahashi Y. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J Biol Chem 1960; 235:1992-7.
4. Erlich SS, Apuzzo ML. The pineal gland: anatomy, physiology, and clinical significance. J Neurosurg 1985; 63:321-41.
5. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12:151-80.
6. Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 2000; 917:376-86.
7. Dubbels R, Reiter RJ, Klenke E, Goebel A, Schnakenberg E, Ehlers C et al. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res 1995; 18:28-31.
8. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden L, Pablos MI, Tan DX. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53:373-82.
9. Markey SP, Riga S, Shih M, Danforth DN, Tamarkin L. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin Chim Acta 1985; 150:221-5.
10. Orts RJ, Benson B. Inhibition effects on serum and pituitary LH by a melatonin-free extract of bovine pineal glands. Life Sci II 1973; 12:513-9.
11. Zang LY, Cosma G, Gardner H, Vallyathan V. Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998; 1425:469-77.
12. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-8.
13. Reppert SM. Melatonin receptors, molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 1997; 12:528-31.
14. Godson C, Reppert SM. The Mella melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 1997; 138:397-404.
15. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92:8734-8.
16. Bubenik GA, Blask DE, Brown GM, Maestroni GJ, Pang SF, Reiter RJ et al. Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998; 7:195-219.
17. Gordijn MC, Beersma DG, Korte HJ, van den Hoofdakker RH. Testing the hypothesis of a circadian phase disturbance underlying depressive mood in nonseasonal depression. J Biol Rhythms 1998; 13:132-47.
18. Rodenbeck A, Huether G, Ruther E, Hajak G. Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders. Adv Exp Med Biol 1999; 467:89-93.
19. Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 2003; 15:432-7.
20. Checkley SA, Murphy DG, Abbas M, Marks M, Winton F, Palazidou E et al. Melatonin rhythms in seasonal affective disorder. Br J Psychiatry 1993; 163:332-7.
21. Turek FW, Dugovic C, Zee PC. Current understanding of the circadian clock and the clinical implications for neurological disorders. Arch Neurol 2001; 58:1781-7.
22. Zee PCGZ. Neurological disorders associated with disturbed sleep and circadian rhythms. In: Turek FWZP, editor. Regulation of sleep and circadian rhythms. New York: Marcel Dekker Inc., 1999:557-96.
23. Galego JC, Cipullo JP, Cordeiro JA, Tognola WA. Clinical features of episodic migraine and transformed migraine: a comparative study. Arq Neuropsiquiatr 2002; 60:912-6.
24. Paiva T, Batista A, Martins P, Martins A. The relationship between headaches and sleep disturbances. Headache 1995; 35:590-6.
25. Silberstein SD. The role of sex hormones in headache. Neurology 1992; 42 (3 Suppl. 2):37-42.
26. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993; 33:385-9.
27. Medina JL, Diamond S. Cyclical migraine. Arch Neurol 1981; 38:343-4.
28. Young WB, Peres MF, Rozen TD. Modular headache theory. Cephalalgia 2001; 21:842-9.
29. Peres MF, Stiles MA, Siow HC, Dogramji K, Silberstein SD, Cipolla-Neto J. Chronobiological features in episodic and chronic migraine. Cephalalgia 2003; 23:590-1.
30. Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 1989; 29:242-5.
31. Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S et al. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994; 14:205-9.
32. Brun J, Claustrat B, Saddier P, Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 1995; 15:136-9.
33. Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 2001; 71:747-51.
34. Claustrat B, Brun J, Geoffriau M, Zaidan R, Mallo C, Chazot G. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia 1997; 17:511-7.
35. Nagtegaal JE, Laurant MW, Kerkhof GA, Smits MG, van der Meer YG, Coenen AM. Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome. J Psychosom Res 2000; 48:45-50.
36. Sandyk R. The influence of the pineal gland on migraine and cluster headaches and effects of treatment with picoTesla magnetic fields. Int J Neurosci 1992; 67: 145-71.
37. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352(9124):275-8.
38. Chazot G, Claustrat B, Brun J, Jordan D, Sassolas G, Schott B. A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache. Cephalalgia 1984; 4:213-20.
39. Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50:207-13.
40. Waldenlind E, Ekbom K, Wetterberg L, Fanciullacci M, Marabini S, Sicuteri F et al. Lowered circannual urinary melatonin concentrations in episodic cluster headache. Cephalalgia 1994; 14:199-204.
41. Leone M, Lucini V, D'Amico D, Moschiano F, Maltempo C, Fraschini F et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995; 15:224-9.
42. Blau JN, Engel HO. A new cluster headache precipitant: increased body heat. Lancet 1999; 354(9183):1001-2.
43. Peres MF, Seabra ML, Zukerman E, Tufik S. Cluster headache and melatonin. Lancet 2000; 355 (9198):147.
44. Leone M, D'Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996; 16:494-6.
45. Peres MF, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia 2001; 21:993-5.
46. Nagtegaal JE, Smits MG, Swart AC, Kerkhof GA, van der Meer YG. Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations. Headache 1998; 38:303-7.
47. Dodick DW, Jones JM, Capobianco DJ. Hypnic headache: another indomethacin-responsive headache syndrome? Headache 2000; 40:830-5.
48. Dodick DW, Eross EJ, Parish JM. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache 2003; 43:282-92.
49. Capo G, Esposito A. Hypnic headache, a new Italian case with a good response to pizotifene and melatonin. Cephalalgie 2001; 21:505-6.
50. Martins IP, Gouveia RG. Hypnic headache and travel across time zones: a case report. Cephalalgia 2001; 21:928-31.
51. Peres MF, Stiles MA, Oshinsky M, Rozen TD. Remitting form of hemicrania continua with seasonal pattern. Headache 2001; 41:592-4.
52. Rozen TD. Melatonin as treatment for indomethacin-responsive headache syndromes. Cephalalgia 2003; 23:734-5.
53. Rozen TD. Melatonin as treatment for idiopathic stabbing headache. Neurology 2003; 61:865-6.
54. Sawamura Y, Ikeda J, Ozawa M, Minoshima Y, Saito H, Abe H. Magnetic resonance images reveal a high incidence of asymptomatic pineal cysts in young women. Neurosurgery 1995; 37:11-5.
55. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999; 282:36-9.
56. Chazot G, Claustrat B, Broussolle E, Lapras C. Headache and depression: recurrent symptoms in adult pinealectomized patients. In: Nappi G, editor. Headache and depression. New York: Raven Press, 1991:299-303.
57. Mandera M, Marcol W, Bierzynska-Macyszyn G, Kluczewska E. Pineal cysts in childhood. Childs Nerv Syst 2003; 19:750-5.
58. Wober-Bingol C, Wober C, Prayer D, Wagner-Ennsgraber C, Karwautz A, Vesely C et al. Magnetic resonance imaging for recurrent headache in childhood and adolescence. Headache 1996; 36:83-90.
59. Peres M, Brandt R, Porto P, Zukerman E. Headaches and pineal cyst: a (more than) coincidental relationship? Cephalalgia 2003; 23:676.
60. Atkinson G, Drust B, Reilly T, Waterhouse J. The relevance of melatonin to sports medicine and science. Sports Med 2003; 33:809-31.
61. Pucci E, Matozzo F, Sandrini G, Costa A, Citterio A, Nappi G. Shift work and headache: observations in a group of hospital workers. Cephalalgia 2003; 23:605.
62. Ho KH, Ong BK. A community-based study of headache diagnosis and prevalence in Singapore. Cephalalgia 2003; 23:6-13.
63. Chuang JI, Mohan N, Meltz ML, Reiter RJ. Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 1996; 20:687-92.
64. Shaikh AY, Xu J, Wu Y, He L, Hsu CY. Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. Neurosci Lett 1997; 229:193-7.
65. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuna-Castroviejo D, Guerrero JM. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20:205-10.
66. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408:297-300.
67. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 2001; 21:605-16.
68. Peroutka SJ. Dopamine and migraine. Neurology 1997; 49:650-6.
69. Ramadan NM. The link between glutamate and migraine. CNS Spectr 2003; 8:446-9.
70. Wang F, Li JC, Wu CF, Yang JY, Xu F, Peng F. Hypnotic activity of melatonin: involvement of semicarbazide hydrochloride, blocker of synthetic enzyme for GABA. Acta Pharmacol Sin 2002; 23:860-4.
71. Wu FS, Yang YC, Tsai JJ. Melatonin potentiates the GABA(A) receptor-mediated current in cultured chick spinal cord neurons. Neurosci Lett 1999; 260:177-80.
72. Espinar A, Garcia-Oliva A, Isorna EM, Quesada A, Prada FA, Guerrero JM. Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo. J Pineal Res 2000; 28:81-8.
73. Zhang QZ, Gong YS, Zhang JT. Antagonistic effects of melatonin on glutamate release and neurotoxicity in cerebral cortex. Zhongguo Yao Li Xue Bao 1999; 20:829-34.
74. Ebadi M, Govitrapong P, Phansuwan-Pujito P, Nelson F, Reiter RJ. Pineal opioid receptors and analgesic action of melatonin. J Pineal Res 1998; 24:193-200.
75. Savaskan E, Olivieri G, Brydon L, Jockers R, Krauchi K, Wirz-Justice A et al. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. Neurosci Lett 2001; 308:9-12.
76. Monnet FP. Melatonin modulates [3h]serotonin release in the rat hippocampus: effects of circadian rhythm. J Neuroendocrinol 2002; 14:194-9.
77. deVries MW, Peeters FP. Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression. J Nerv Ment Dis 1997; 185:201-2.